By KK Rumrill, Global Head, Trial Design & Site Engagement, IQVIA Technologies
The COVID-19 pandemic is presenting unprecedented challenges to the clinical trial industry. Distancing measures combined with varied local and national mitigation efforts have not only impacted patient and provider interactions but also communication between sponsors and sites. Sites are in an unprecedented state of flux, and the pressure to understand the situation, protect patients and providers, and determine how to ensure continuity is on. Now more than ever, strong communication channels between sponsors and sites are critical.
In this environment, the community-building Site Engagement module of our Investigator Site Portal is proving to be crucial.